Video Series: Current Topics in the Treatment of Advanced PCa
Philip Kantoff, MD, Andrew Armstrong, MD, William Oh, MD, and A. Oliver Sartor, MD, discuss advances in treatment of castration-resistant prostate cancer and metastatic castration-resistant prostate cancer, specifically newer hormonal therapies.
Latest Prostate Cancer News
Most patients have unrealistic survival expectations, which may compromise their ability to make informed treatment decisions.
Patients with a relatively low tumor risk and good general health status appear to experience the best survival.
In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.
High rates of screening for individuals with limited long-term life expectancy for all tools.
Multiple studies suggest they might.
Researchers found an adjusted 68% decreased risk of prostate cancer in men with IBD who used aminosalicylate.
Prostate cancer patients taking proton pump inhibitors also had pathologically higher stage disease.
The higher the baseline PSA levels, the greater the risk of being diagnosed with any or significant prostate cancer.
Minimally invasive surgery is associated with a lower incidence of bladder neck contracture.
Study documents superior recurrence- and metastasis-free survival compared with cT1b tumors.
A biologic effective dose less than 170 Gy2 is associated with a 2-fold increase risk dying from prostate cancer versus higher doses.
The chances of erectile function recovery improved when patients received radiation treatment more than 16 months after surgery.
In a study, use of the medication was associated with a significant 61% decreased risk.
In fact, some data suggest treatment may reduce prostate cancer incidence and aggressiveness.
The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.
Prostate Cancer Videos
Sign up for free e-Newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- CKD Progression After Acute Kidney Injury Characterized
- High Sodium Intake May Up CVD Risk in CKD Patients
- Guidelines Recommend Weight-loss Surgery to Treat Type 2 Diabetes
- Achieving 4 Lifestyle Standards May Reduce Cancer Mortality
- Fluid Overload at RRT Initiation Ups AKI Patients' Long-Term Mortality